1. Home
  2. EPIX vs GEOS Comparison

EPIX vs GEOS Comparison

Compare EPIX & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • GEOS
  • Stock Information
  • Founded
  • EPIX 2009
  • GEOS 1980
  • Country
  • EPIX Canada
  • GEOS United States
  • Employees
  • EPIX N/A
  • GEOS N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • GEOS Industrial Machinery/Components
  • Sector
  • EPIX Health Care
  • GEOS Industrials
  • Exchange
  • EPIX Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • EPIX 75.9M
  • GEOS 72.9M
  • IPO Year
  • EPIX N/A
  • GEOS 1997
  • Fundamental
  • Price
  • EPIX $1.93
  • GEOS $16.25
  • Analyst Decision
  • EPIX Hold
  • GEOS
  • Analyst Count
  • EPIX 3
  • GEOS 0
  • Target Price
  • EPIX $2.00
  • GEOS N/A
  • AVG Volume (30 Days)
  • EPIX 304.7K
  • GEOS 233.3K
  • Earning Date
  • EPIX 08-13-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • EPIX N/A
  • GEOS N/A
  • EPS Growth
  • EPIX N/A
  • GEOS N/A
  • EPS
  • EPIX N/A
  • GEOS N/A
  • Revenue
  • EPIX N/A
  • GEOS $115,527,000.00
  • Revenue This Year
  • EPIX N/A
  • GEOS N/A
  • Revenue Next Year
  • EPIX N/A
  • GEOS N/A
  • P/E Ratio
  • EPIX N/A
  • GEOS N/A
  • Revenue Growth
  • EPIX N/A
  • GEOS N/A
  • 52 Week Low
  • EPIX $1.40
  • GEOS $5.51
  • 52 Week High
  • EPIX $7.88
  • GEOS $18.99
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 71.19
  • GEOS 58.54
  • Support Level
  • EPIX $1.90
  • GEOS $12.59
  • Resistance Level
  • EPIX $1.93
  • GEOS $16.05
  • Average True Range (ATR)
  • EPIX 0.01
  • GEOS 1.52
  • MACD
  • EPIX -0.00
  • GEOS -0.16
  • Stochastic Oscillator
  • EPIX 100.00
  • GEOS 57.91

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: